What is it about?

Infections with drug resistant bacteria and emerging outbreaks of infections such as Ebola and Zika virus infections are potential threats to public health. Lack of effective treatments for drug-resistant bacteria and recent outbreaks of Ebola and Zika viral infections have become a global public health concern. While the drug resistant bacteria have increased with the over use of antibiotics, the numbers of newly approved antibiotics have decreased significantly in the last two decades due to the difficulties in finding new broad spectrum antibiotics. New strategies and technology platforms are critically needed to counter these threats and challenges. In this review article, we have reviewed the drug repurposing and synergistic drug combination as alternative approaches for rapid identification of effective therapeutics to treat the infectious diseases. We also have evaluated the feasibility of development of new narrow spectrum antibiotics for treatment of infections with drug resistant bacteria that can be developed quickly with collaborative efforts including government, academic researchers and private drug industry.

Featured Image

Read the Original

This page is a summary of: Drug repurposing screens and synergistic drug‐combinations for infectious diseases, British Journal of Pharmacology, July 2017, Wiley,
DOI: 10.1111/bph.13895.
You can read the full text:

Read

Contributors

Be the first to contribute to this page